Karyopharm Therapeutics reported $3.87M in Stock for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Abbott ABT:US $ 5691M 534M
Abbvie ABBV:US $ 3483M 355M
Amgen AMGN:US $ 4411M 325M
Biocryst Pharmaceuticals BCRX:US $ 16.14M 0.35M
Bristol Myers Squibb BMY:US $ 2104M 9M
Eli Lilly And LLY:US $ 3893M 7M
GlaxoSmithKline GSK:LN 6003M 220M
Johnson & Johnson JNJ:US $ 10990M 603M
Karyopharm Therapeutics KPTI:US $ 3.87M 232K
Macrogenics MGNX:US $ 4.6M 0.21M
Merk MRK:US $ 5774M 179M
Nektar Therapeutics NKTR:US $ 15.38M 0.42M
Novartis NOVN:VX SF 6997M 331M
Pfizer PFE:US $ 9979M 920M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Takeda 4502:JP Y 853167M 41843M
Ultragenyx Pharmaceutical RARE:US $ 17.81M 1.58M
YTE INCY:US $ 35.46M 7.55M